rs114904067 - RPL36AP23 - LINC02945
Magnitude 2.2 · 1 study on file
Reported associations
-
Biobank-driven genomic discovery yields new insight into atrial fibrillation biology - Unknown journal (n.d.) · Unknown authors · PubMed 30061737
ABSTRACT: To identify genetic variation underlying atrial fibrillation, the most common cardiac arrhythmia, we performed a genome-wide association study of > 1,000,000 people, including 60,620 atrial fibrillation cases and 970,216 controls. We identified 142 independent risk variants at 111 loci and prioritized 151 functional candidate genes likely to be involved in atrial fibrillation. Many of the identified risk variants fall near genes where more deleterious mutations have been reported to cause serious heart defects in humans (GATA4, MYH6, NKX2-5, PITX2, TBX5), or near genes important for striated muscle function and integrity (for example, CFL2 MYH7, PKP2, RBM20, SGCG, SSPN). Pathway and functional enrichment analyses also suggested that many of the putative atrial fibrillation gene
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Screening
-
atrial fibrillation monitoring Moderate
Genetic variant at RPL36AP23/LINC02945 increases atrial fibrillation risk; periodic cardiac monitoring enables early detection.
Baseline ECG; discuss with physician regarding monitoring schedule given genetic predisposition.